Back to Journals » ImmunoTargets and Therapy » Volume 4

Update on use of aldesleukin for treatment of high-risk metastatic melanoma

Total article views   HTML views PDF downloads Totals
16,731 Dovepress* 12,234+ 2,010 14,244
PubMed Central* 4,497 628 5,125
Totals 16,731 2,638 19,369
*Since 7 April 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar